DOSSIER · 13F-HR · Q1 2026

Davern Capital Partners, LP

$365M in tracked AUM across 17 positions as of Q1 2026.

DC
CIK 0002003147 · last filed Mar 31, 2026
Total AUM
$365M
as of Q1 2026
Holdings
17
positions
Whale Score
66
66
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Davern Capital Partners, LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
PFE
PFIZER INC
$45M1.6M12.3%
02
REGN
REGENERON PHARMACEUTICALS
$35M45K9.5%
03
INSM
INSMED INC
$30M183K8.2%
04
IONS
IONIS PHARMACEUTICALS INC
$29M387K8.0%
05
NTRA
NATERA INC
$29M144K7.9%
06
BNTX
BIONTECH SE
$27M305K7.4%
07
ARGX
ARGENX SE
$26M35K7.0%
08
LLY
ELI LILLY & CO
$25M27K6.9%
09
G7709Q104
ROYALTY PHARMA PLC
$25M520K6.8%
10
G76279101
ROIVANT SCIENCES LTD
$24M873K6.6%

Filing history

2026Q1Mar 31
$365M 17.9%
17 positionsView →
2025Q4Dec 31
$309M
14 positionsView →